Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report)’s share price traded up 0.5% on Thursday . The stock traded as high as $48.77 and last traded at $48.77. 362 shares were traded during trading, a decline of 57% from the average session volume of 850 shares. The stock had previously closed at $48.51.
Hikma Pharmaceuticals Stock Down 0.4 %
The business has a fifty day moving average price of $49.47 and a two-hundred day moving average price of $50.07.
Hikma Pharmaceuticals Company Profile
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
See Also
- Five stocks we like better than Hikma Pharmaceuticals
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Oil Titans Face Off: Exxon Mobil or Chevron for 2025 Gains?
- What is the FTSE 100 index?
- Mining Stocks Back in the Spotlight: 3 Key Names to Watch
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- MarketBeat Week in Review – 12/16 – 12/20
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
